Elicera Therapeutics
BioStock: Elicera's CEO: "ELC-100 stands apart from all other standard treatments"
Read the interview at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Datum | 2024-11-27, kl 11:28 |
Källa | Cision |

Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.